Who’s Hired? Makov To Step Away From Sun Pharma After 10 Years
Updates Also Announced By Mayne, Avet, Amneal And AAM
While Israel Makov steps away from Sun Pharmaceuticals, Mayne and Avet bring in new executives, Amneal appoints a new director and the AAM promotes a loyal colleague.
You may also be interested in...
Dan Leonard has announced his resignation as president and CEO of the US Association for Accessible Medicines. He will be replaced on an interim basis by the group’s vice president for sciences and regulatory affairs, David Gaugh.
Looking back over the third quarter of 2022, Generics Bulletin executive editor Dave Wallace picks out highlights from July to September that include changes in ownership on the horizon for major industry players, executive reshuffles at the top of leading companies and regulators, Generics Bulletin’s annual Top 50 and the announcement of our annual awards shortlist.
Summer’s end brings notable leadership reshuffles across four continents and five companies. Stada has appointed its head of mid-sized European markets as its UK lead while Gustavo Pesquin joins Amneal from Sanofi.